Influencing factors of COVID-19 vaccination hesitancy among adults in Taiwan, China: a cross-sectional study

Author:

Huang Chun-Lian1,Chen Jau-Yuan2,Chen Xiao-ying1,Lin Xiao-Qing1,Deng Jing-Shan1,Tung Tao-Hsin1,Zhu Jian-Sheng1

Affiliation:

1. Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University

2. Taizhou Hospital of Zhejiang Province, Wenzhou Medical University

Abstract

Abstract Objectives The promotion of the COVID-19 vaccine is key to controlling the spread of COVID-19. One of the most significant obstacles in tackling the pandemic is vaccine hesitancy. While many published studies have examined vaccine hesitancy among adults, there is a dearth of such studies exploring vaccine hesitancy among adults in Taiwan, China.Study design and Methods We surveyed 384 adults in Taiwan from July 14 to September 23, 2021. Using a Chi-square test and a binary logistic regression, we examined the prevalence of COVID-19 vaccine hesitancy and the factors influencing this. In addition, we summarized the regional differences in vaccine hesitancy across China that was reported by previous research.Results Overall, 64.3% of participants were hesitant to be vaccinated. Gender and perception of the safety of the COVID-19 vaccine was identified as a risk factor for vaccine hesitancy. Additionally, hesitancy in mainland China was found to be lower than that in Taiwan and Hong Kong.Conclusion The results of this study highlight the attitudes of the adults towards vaccination and the factors that influence it. The results can inform the government’s development of epidemic prevention and control policies that would improve vaccine uptake.

Publisher

Research Square Platform LLC

Reference50 articles.

1. MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015 Aug 14;33(34):4161-4. doi: 10.1016/j.vaccine.2015.04.036. PubMed PMID: 25896383; eng.

2. Who is more likely to hesitate to accept COVID-19 vaccine: a cross-sectional survey in China;Zhang P;Expert Rev Vaccines

3. Acceptance of COVID-19 booster vaccination based on the protection motivation theory: A cross-sectional study in China;Wu F;J Med Virol

4. Fiolet T, Kherabi Y, MacDonald CJ et al. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2022 Feb;28(2):202–221. doi: 10.1016/j.cmi.2021.10.005. PubMed PMID: 34715347; PubMed Central PMCID: PMCPMC8548286. eng.

5. Zhou H, Møhlenberg M, Thakor JC et al. Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant. Clinical microbiology reviews. 2022 Sep 21;35(3):e0001422. doi: 10.1128/cmr.00014-22. PubMed PMID: 35862736; PubMed Central PMCID: PMCPMC9491202. eng.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3